Literature DB >> 21318814

Fluorescence in situ hybridization : application in cancer research and clinical diagnostics.

S D Pack1, Z Zhuang.   

Abstract

An opportunity to look inside of the individual cell for the direct visualization in situ of "what happened?" is the most wonderful feature offered by fluorescence in situ hybridization (FISH). DNA in situ hybridization is a technique that allows the visualization of defined sequences of nucleic acids within the individual cells. The method is based on the site specific annealing (hybridization) of single-stranded labeled DNA fragments (probes) to denatured, homologous sequences (targets) on cytological preparations, like metaphase chromosomes, interphase nuclei, or naked chromatin fibers. Visualization of hybridization sites becomes possible after detection steps by using a wide spectrum of the fluorescent dyes available.

Entities:  

Year:  2001        PMID: 21318814     DOI: 10.1385/1-59259-084-5:35

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  12 in total

1.  CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.

Authors:  Mary E Olanich; Wenyue Sun; Stephen M Hewitt; Zied Abdullaev; Svetlana D Pack; Frederic G Barr
Journal:  Clin Cancer Res       Date:  2015-03-25       Impact factor: 12.531

2.  Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma.

Authors:  Armin G Jegalian; Franziska C Eberle; Svetlana D Pack; Mariya Mirvis; Mark Raffeld; Stefania Pittaluga; Elaine S Jaffe
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

3.  Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma.

Authors:  Katerina Hadrava Vanova; Ying Pang; Linda Krobova; Michal Kraus; Zuzana Nahacka; Stepana Boukalova; Svetlana D Pack; Renata Zobalova; Jun Zhu; Thanh-Truc Huynh; Ivana Jochmanova; Ondrej Uher; Sona Hubackova; Sarka Dvorakova; Timothy J Garrett; Hans K Ghayee; Xiaolin Wu; Bjoern Schuster; Philip E Knapp; Zdenek Frysak; Igor Hartmann; Naris Nilubol; Jiri Cerny; David Taieb; Jakub Rohlena; Jiri Neuzil; Chunzhang Yang; Karel Pacak
Journal:  J Natl Cancer Inst       Date:  2022-01-11       Impact factor: 13.506

4.  Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion.

Authors:  Navid Sadri; Julieta Barroeta; Svetlana D Pack; Zied Abdullaev; Bishwanath Chatterjee; Raghunath Puthiyaveettil; John S Brooks; Frederic G Barr; Paul J Zhang
Journal:  Virchows Arch       Date:  2014-07-04       Impact factor: 4.064

5.  ERG expression in epithelioid sarcoma: a diagnostic pitfall.

Authors:  Markku Miettinen; Zengfeng Wang; Maarit Sarlomo-Rikala; Ziedulla Abdullaev; Svetlana D Pack; John F Fetsch
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

6.  Von hippel-lindau disease associated pulmonary carcinoid with cranial metastasis.

Authors:  Chao Zhang; Andrew I Yang; Lucas Vasconcelos; Seog Moon; Chunzhang Yang; Cody L Nesvick; Lola Saidkhodjaeva; Ziedulla Abdullaev; Svetlana D Pack; Arunima Ghosh; Prashant Chittiboina; John D Heiss; Zhengping Zhuang; Martha M Quezado; Kareem A Zaghloul
Journal:  J Clin Endocrinol Metab       Date:  2014-05-30       Impact factor: 5.958

7.  Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer.

Authors:  Anish Thomas; Jih-Hsiang Lee; Zied Abdullaev; Kang-Seo Park; Marbin Pineda; Lola Saidkhodjaeva; Markku Miettinen; Yisong Wang; Svetlana D Pack; Giuseppe Giaccone
Journal:  J Thorac Oncol       Date:  2014-04       Impact factor: 15.609

8.  Early lesions of follicular lymphoma: a genetic perspective.

Authors:  Emilie Mamessier; Joo Y Song; Franziska C Eberle; Svetlana Pack; Charlotte Drevet; Bruno Chetaille; Ziedulla Abdullaev; José Adelaïde; Daniel Birnbaum; Max Chaffanet; Stefania Pittaluga; Sandrine Roulland; Andreas Chott; Elaine S Jaffe; Bertrand Nadel
Journal:  Haematologica       Date:  2013-10-25       Impact factor: 9.941

9.  High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis.

Authors:  Anish Thomas; Yuanbin Chen; Seth M Steinberg; Ji Luo; Svetlana Pack; Mark Raffeld; Zied Abdullaev; Christine Alewine; Arun Rajan; Giuseppe Giaccone; Ira Pastan; Markku Miettinen; Raffit Hassan
Journal:  Oncotarget       Date:  2015-05-10

10.  Tumor derived vasculogenesis in von Hippel-Lindau disease-associated tumors.

Authors:  Zhengping Zhuang; Jason M Frerich; Kristin Huntoon; Chunzhang Yang; Marsha J Merrill; Ziedulla Abdullaev; Svetlana D Pack; Sharon B Shively; Gordon Stamp; Russell R Lonser
Journal:  Sci Rep       Date:  2014-02-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.